In the high malaria transmission setting of Uganda where HRP2-based RDTs are recommended, poor specificity of HRP2-only RDTs due to persistent HRP2 antigenaemia is common and may result in inappropriate use of anti-malarial drugs [11, 12, 48]. Here, HDGFL2 is linked to malaria.